NeuroPace, Inc. (NPCE)
7.95
-0.19
(-2.33%)
USD |
NASDAQ |
Nov 20, 16:00
8.06
+0.11
(+1.38%)
After-Hours: 20:00
NeuroPace Shareholders Equity (Quarterly) : 11.49M for Sept. 30, 2026
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 11.49M |
| June 30, 2026 | 11.88M |
| March 31, 2026 | 14.45M |
| December 31, 2025 | 19.03M |
| September 30, 2025 | 18.52M |
| June 30, 2025 | 19.44M |
| March 31, 2025 | 24.27M |
| December 31, 2024 | 8.013M |
| September 30, 2024 | 9.823M |
| June 30, 2024 | 9.885M |
| March 31, 2024 | 14.34M |
| December 31, 2023 | 20.65M |
| Date | Value |
|---|---|
| September 30, 2023 | 16.36M |
| June 30, 2023 | 21.23M |
| March 31, 2023 | 27.49M |
| December 31, 2022 | 34.78M |
| September 30, 2022 | 43.41M |
| June 30, 2022 | 52.90M |
| March 31, 2022 | 62.82M |
| December 31, 2021 | 73.50M |
| September 30, 2021 | 81.71M |
| June 30, 2021 | 88.67M |
| March 31, 2021 | -15.01M |
| December 31, 2020 | -6.41M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Tandem Diabetes Care, Inc. | 135.09M |
| Axogen, Inc. | 496.10M |
| Accuray, Inc. | 53.12M |
| Orthofix Medical, Inc. | 429.57M |
| ResMed, Inc. | 5.948B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 94.78M |
| Total Liabilities (Quarterly) | 83.28M |
| Debt to Equity Ratio | 6.051 |
| Current Ratio | 5.261 |
| Net Debt Paydown Yield | 0.08% |